With a market cap of $252.6 billion, Rahway, New Jersey-based Merck & Co., Inc. (MRK) is a global leader in the healthcare ...

China NMPA grants expanded approval for Merck’s Gardasil for use in males 9-26 years of age to help prevent certain HPV-related cancers & diseases: Rahway, New Jersey Friday, Ja ...

The HPV vaccine, Gardasil, has gained approval for additional indications from China's National Medical Products ...

The China National Medical Products Administration (NMPA) has granted expanded approval to MSD's GARDASIL, [Human ...

Merck's Gardasil vaccine, previously only available to women, has now been approved for men in China. This approval may help ...

Merck's human papillomavirus vaccine has been approved for men in China, it said on Wednesday, providing the U.S. drugmaker a ...

GARDASIL is the first HPV vaccine approved for the prevention of certain HPV-related cancers and diseases in Chinese males ...

Merck & Co's human papillomavirus (HPV) vaccine, Gardasil, has received approval from China's medical products administration ...

U.S. drugmaker Merck & Co said on Wednesday its human papillomavirus (HPV) vaccine for men has been approved by China's ...

U.S. drugmaker Merck & Co on Wednesday announced that its human papillomavirus (HPV) vaccine for men has been approved by ...

U.S. drugmaker Merck & Co has received approval in China for its HPV vaccine's use in males, expanding its market reach despite earlier weak sales in the region. This move marks a potential growth ...

People across the world are observing Cervical Awareness Month in January to raise awareness about the disease. Now, let us ...